Evaluating the 2023 EASL guidelines for intrahepatic cholestasis of pregnancy: risk stratification and outcomes in over 4,000 U.S. patients

Esophagus Diseases

Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Barrett's Esophagus Patients

Am J Gastroenterol

Laun SE, Kann L, Braun J, Pierre F, Kim S, Gilbert S, Lunz D, Kalra A, Ma K, Cheng Y, Leggett CL, Zaidi AH, Omstead AN, Korman L, Jobe B, Perpetua L, Greenwald BD, Maddala T, Meltzer SJ

doi: 10.14309/ajg.0000000000003367

Hepatology

Effectiveness of six international guidelines using FIB-4 and FibroScan for risk stratification of MASLD in type 2 diabetes

Clin Gastroenterol Hepatol

Vidal-Trécan T, Julla JB, El Khoury T, Venteclef N, Riveline JP, Paradis V, Valla D, Gautier JF, Castera L

doi: 10.1016/j.cgh.2025.02.018

ColonoscopyGastrointestinal Cancer

Utility of quantitative fecal immunochemical test values for average risk colorectal cancer screening risk stratification among patients with a positive test

Am J Gastroenterol

H-E Kang J, Jensen CD, Merchant S, Selby K, Badalov JM, Corley DA, Levin TR, Lee JK

doi: 10.14309/ajg.0000000000003805

Hepatology

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

Hepatology

Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Gutierrez ML, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Balcar L, Carbonell-Asins JA, Gschwantler M, Russo FP, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M

doi: 10.1097/HEP.0000000000001005

Gastrointestinal Cancer

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study

Lancet Gastroenterol Hepatol

Mahajan UM, Oehrle B, Goni E, Strobel O, Kaiser J, Grützmann R, Werner J, Friess H, Gress TM, Seufferlein TW, Uhl W, Will U, Neoptolemos JP, Wittel UA, Vornhülz M, Sirtl S, Beyer G, Regel I, Boeck S, Heinemann V, Frost F, Steveling A, Völzke H, Petersmann A, Nauck M, Weber E, Kamlage B, Lerch MM, Mayerle J, METAPAC trial investigators

doi: 10.1016/S2468-1253(25)00056-1

Inflammatory Bowel Disease

Impact of Type 2 Diabetes on Clinical Outcomes and Advanced Therapy Use in Patients with Crohn's Disease: a Real-World Propensity Score-Matched Analysis

J Crohns Colitis

Massironi S, Solitano V, Furfaro F, D'Amico F, Zilli A, Allocca M, Peyrin-Biroulet L, Jairath V, Danese S

doi: 10.1093/ecco-jcc/jjaf157

Inflammatory Bowel Disease

Longitudinal Profiles of Fecal Calprotectin and C-Reactive Protein in Relation to Outcomes in Crohn's Disease Patients on Infliximab

J Crohns Colitis

Magro F, Domingues B, Estevinho MM, Patita M, Arroja B, Lago P, Rosa I, de Sousa HT, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Cancela E, Sousa P, Portela F, Correia L, Fernandes S, Dias CC, Dias S, Peyrin-Biroulet L, Danese S, Santiago M, GEDII

doi: 10.1093/ecco-jcc/jjaf120

Esophagus DiseasesGastroesophageal Reflux Disease (GERD)

VALIDATION OF ESOPHAGEAL GLOBAL SYMPTOM SEVERITY AS A PATIENT REPORTED OUTCOME FOR EVALUATION OF REFLUX SYMPTOMS

Am J Gastroenterol

Chan WW, Schroeder M, Richardson A, Shah N, Muftah M, Muftah S, Siboni S, Sozzi M, Wong MW, Chen CL, Gyawali CP, Milan Score Working Group

doi: 10.14309/ajg.0000000000003499

Inflammatory Bowel Disease

Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension Study

J Crohns Colitis

Loftus EV Jr, D'Haens G, Louis E, Regueiro M, Jairath V, Magro F, Nakase H, Dubcenco E, Lacerda AP, Ford S, Feng T, Duncan B, Fish I, Cunneen C, Anyanwu SI, Aponte F, Griffith J, Blumenstein I

doi: 10.1093/ecco-jcc/jjaf138

Related content

Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Barrett's Esophagus Patients

Effectiveness of six international guidelines using FIB-4 and FibroScan for risk stratification of MASLD in type 2 diabetes

Utility of quantitative fecal immunochemical test values for average risk colorectal cancer screening risk stratification among patients with a positive test

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study

Impact of Type 2 Diabetes on Clinical Outcomes and Advanced Therapy Use in Patients with Crohn's Disease: a Real-World Propensity Score-Matched Analysis

Longitudinal Profiles of Fecal Calprotectin and C-Reactive Protein in Relation to Outcomes in Crohn's Disease Patients on Infliximab

VALIDATION OF ESOPHAGEAL GLOBAL SYMPTOM SEVERITY AS A PATIENT REPORTED OUTCOME FOR EVALUATION OF REFLUX SYMPTOMS

Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: 2-Year Results from the U-ENDURE Long-Term Extension Study